Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium
Open Access
- 30 September 2011
- journal article
- research article
- Published by Springer Nature in Journal of Muscle Research and Cell Motility
- Vol. 32 (3) , 221-233
Abstract
Protein phosphatase (PP) type 2A is a multifunctional serine/threonine phosphatase that is involved in cardiac excitation–contraction coupling. The PP2A core enzyme is a dimer, consisting of a catalytic C and a scaffolding A subunit, which is targeted to several cardiac proteins by a regulatory B subunit. At present, it is controversial whether PP2A and its subunits play a critical role in end-stage human heart failure. Here we report that the application of purified PP2AC significantly increased the Ca2+-sensitivity (ΔpCa50 = 0.05 ± 0.01) of the contractile apparatus in isolated skinned myocytes of non-failing (NF) hearts. A higher phosphorylation of troponin I (cTnI) was found at protein kinase A sites (Ser23/24) in NF compared to failing myocardium. The basal Ca2+-responsiveness of myofilaments was enhanced in myocytes of ischemic (ICM, ΔpCa50 = 0.10 ± 0.03) and dilated (DCM, ΔpCa50 = 0.06 ± 0.04) cardiomyopathy compared to NF. However, in contrast to NF myocytes the treatment with PP2AC did not shift force-pCa relationships in failing myocytes. The higher basal Ca2+-sensitivity in failing myocytes coincided with a reduced protein expression of PP2AC in left ventricular tissue from patients suffering from ICM and DCM (by 50 and 56% compared to NF, respectively). However, PP2A activity was unchanged in failing hearts despite an increase of both total PP and PP1 activity. The expression of PP2AB56α was also decreased by 51 and 62% in ICM and DCM compared to NF, respectively. The phosphorylation of cTnI at Ser23/24 was reduced by 66 and 49% in ICM and DCM compared to NF hearts, respectively. Our results demonstrate that PP2A increases myofilament Ca2+-sensitivity in NF human hearts, most likely via cTnI dephosphorylation. This effect is not present in failing hearts, probably due to the lower baseline cTnI phosphorylation in failing compared to non-failing hearts.Keywords
This publication has 55 references indexed in Scilit:
- More severe cellular phenotype in human idiopathic dilated cardiomyopathy compared to ischemic heart diseaseJournal of Muscle Research and Cell Motility, 2010
- Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation backgroundJournal of Molecular and Cellular Cardiology, 2010
- Proteomics Analysis of the Cardiac Myofilament Subproteome Reveals Dynamic Alterations in Phosphatase Subunit DistributionMolecular & Cellular Proteomics, 2010
- Protein kinase C α and ε phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardiumBasic Research in Cardiology, 2009
- Prevention of Myofilament Dysfunction by β-Blocker Therapy in Postinfarct RemodelingCirculation: Heart Failure, 2009
- Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemiaCardiovascular Research, 2009
- Regulation of the ankyrin-B-based targeting pathway following myocardial infarctionCardiovascular Research, 2008
- JNK activation decreases PP2A regulatory subunit B56α expression and mRNA stability and increases AUF1 expression in cardiomyocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Increased Expression of Cardiac Phosphatases in Patients with End-stage Heart FailureJournal of Molecular and Cellular Cardiology, 1997
- Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation.Journal of Clinical Investigation, 1996